Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Mucus-controlling agents: past and present.

M King1, B K Rubin

  • 1Pulmonary Research Group, University of Alberta, Edmonton, Alberta, Canada.

Respiratory Care Clinics of North America
|November 24, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Year in review: "Best" papers in pediatric pulmonary and sleep medicine in 2025.

Paediatric respiratory reviews·2026
Same author

Rational use of mucoactive medications to treat pediatric airway disease.

Paediatric respiratory reviews·2020
Same author

Effect of a single 1200 Mg dose of Mucinex® on mucociliary and cough clearance during an acute respiratory tract infection.

Respiratory medicine·2015
Same author

IL-33 stimulates CXCL8/IL-8 secretion in goblet cells but not normally differentiated airway cells.

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology·2014
Same author

Bordetella bronchiseptica in a paediatric cystic fibrosis patient: possible transmission from a household cat.

Zoonoses and public health·2012
Same author

IL-13-induced MUC5AC production and goblet cell differentiation is steroid resistant in human airway cells.

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology·2011
Same journal

Indirect calorimetry: relevance to patient outcome.

Respiratory care clinics of North America·2006
Same journal

Indirect calorimetry: applications in practice.

Respiratory care clinics of North America·2006
Same journal

Strategies to prevent aspiration-related pneumonia in tube-fed patients.

Respiratory care clinics of North America·2006
Same journal

Feeding the critically ill obese patient: the role of hypocaloric nutrition support.

Respiratory care clinics of North America·2006
Same journal

Nutrition support for the long-term ventilator-dependent patient.

Respiratory care clinics of North America·2006
Same journal

A nutritional strategy to improve oxygenation and decrease morbidity in patients who have acute respiratory distress syndrome.

Respiratory care clinics of North America·2006
See all related articles

Combinations of mucoactive medications may improve airway mucus clearability. Further research is needed to confirm these findings in patients with pulmonary diseases.

Area of Science:

  • Pulmonary Medicine
  • Biochemistry

Background:

  • Airway mucus, a complex mixture of water, glycoproteins, ions, proteins, and lipids, is crucial for airway defense.
  • The physical properties of mucus significantly impact its clearance from the airways.
  • Understanding the factors influencing mucus properties is key to developing effective treatments.

Purpose of the Study:

  • To explore potential pharmacologic strategies for improving airway mucus clearability.
  • To investigate the additive effects of combined mucoactive medications on mucus properties.

Main Methods:

  • In vitro assessment of mucus properties.
  • Evaluation of selected combinations of mucoactive medications.

Main Results:

Related Experiment Videos

  • In vitro results indicate that certain combinations of mucoactive drugs may offer additive benefits.
  • These findings suggest a potential for improved mucus clearability with combined therapies.

    • Conclusions:

    • Pharmacologic strategies, particularly combinations of mucoactive medications, show promise for enhancing airway mucus clearability.
    • Further in vivo studies are necessary to validate these findings in patients with various pulmonary conditions requiring mucoactive treatment.